In Maryland, scientists have long known that breast cancer stem cells can survive chemotherapy, which is not good as those cells are usually in tumor centers and the ones you really want to get rid of because if they come back, the cancer is often fatal. Scientists found that proteins known as hypoxia-inducible factors (HIFs) are activated when exposed to chemotherapy and they then produce a protein called glutathione-S-transferase O1 (GSTO1) which turns on certain genes that help those nasty breast cancer stem cells survive. The gene expression analysis and experiments conducted in their lab showed that if they can block the HIFs, then the GSTO1 protein is never formed and the breast cancer stem cells couldn’t protect themselves against the chemotherapy, giving much hope for breast cancer patients.
Latest article
Bio-hybrid robot made from langoustine shells works like arcade claw crane
In Switzerland, scientists at École Polytechnique Fédérale de Lausanne have converted shellfish shells into claws that grip, not unlike the prize-filled claw machines found...
Holy Carp! makes waves as biodegradable single-use soy sauce alternative
In Australia, design studios Heliograf and Vert Design have jointly developed a biodegradable alternative to whimsical—but polluting—plastic fish-shaped soy sauce containers often seen with...
Pineapple hair ties win Fowler Business Concept Challenge
In California, a University of San Diego graduate student has won a $15,000 scholarship to advance her pineapple leaf hair ties.
Sage Dobby, who...